Literature DB >> 30298363

The intact nephron hypothesis as a model for renal drug handling.

Sudeep Pradhan1, Stephen B Duffull1, Robert J Walker2, Daniel F B Wright3.   

Abstract

PURPOSE: The intact nephron hypothesis (INH) states that impaired renal function results from a reduction in the number of complete (intact) nephrons. Under this model, renal drug clearance is assumed to be a linear function of glomerular filtration while tubular handling is ignored. The aims of this study were to systematically review published studies designed to test the INH and to assess the strength of the study designs used.
METHODS: A systematic literature search was conducted in MEDLINE, EMBASE and Google Scholar. Studies specifically designed to understand the relationship between glomerular and tubular function across different levels of renal function were included. Studies that found a linear relationship between GFR and tubular clearance were deemed to support the INH while studies that found a non-linear relationship did not support the INH. Study design was accessed using a bespoke strength of evidence score.
RESULTS: Thirty studies met the criteria for inclusion. Of these, 24 did not support the INH. Studies that did not support the INH used methods for measuring tubular clearance that were more robust and included subjects with a wider range of GFR values than studies that supported the INH. DISCUSSION: Our results suggest that the INH may not be a suitable general model for renal drug handling, particularly for drugs that are eliminated by tubular mechanisms. Further studies to assess the clinical importance of a non-linear relationship between drug clearance and GFR are warranted.

Entities:  

Keywords:  Intact nephron hypothesis; Renal dose adjustment; Renal drug handling; Systematic review

Mesh:

Substances:

Year:  2018        PMID: 30298363     DOI: 10.1007/s00228-018-2572-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  Ampicillin pharmacokinetics in azotemic and healthy dogs.

Authors:  Kelly N Monaghan; Mary Anna Labato; Mark G Papich
Journal:  J Vet Intern Med       Date:  2021-01-20       Impact factor: 3.333

Review 2.  Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.

Authors:  Francesca De Santis; Andrea Boari; Francesco Dondi; Paolo Emidio Crisi
Journal:  Animals (Basel)       Date:  2022-01-21       Impact factor: 2.752

3.  PBPK Simulation-Based Evaluation of Ganciclovir Crystalluria Risk Factors: Effect of Renal Impairment, Old Age, and Low Fluid Intake.

Authors:  Daniel Scotcher; Aleksandra Galetin
Journal:  AAPS J       Date:  2021-12-14       Impact factor: 4.009

4.  Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically-Based Pharmacokinetic Modeling and Dose Adjustment.

Authors:  Shawn Pei Feng Tan; Daniel Scotcher; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  Clin Pharmacol Ther       Date:  2022-06-13       Impact factor: 6.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.